NRIX
Nurix Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$22.71-1.77%
Price as of Jul 20, 2026
NRIX valuation
Nurix Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 35.60x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.83x
- Price / sales
- 63.87x
- Price / cash flow
- -8.00x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 53.39x
- EV / EBITDA
- -6.14x
- EV / EBIT
- -5.43x
- Market cap
- $2.3B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.